PARP Inhibitor Upregulates PD-L1 Expression and Provides a New Combination Therapy in Pancreatic Cancer.
Wang Y, Zheng K, Xiong H, Huang Y, Chen X, Zhou Y, Qin W, Su J, Chen R, Qiu H, Yuan X, Wang Y, Zou Y.
Wang Y, et al. Among authors: zheng k.
Front Immunol. 2021 Dec 17;12:762989. doi: 10.3389/fimmu.2021.762989. eCollection 2021.
Front Immunol. 2021.
PMID: 34975854
Free PMC article.